In vivo and in vitro impact of atorvastatin against myocardial ischaemia-reperfusion injury by upregulation of silent information regulator l and attenuation of endoplasmic reticulum stress-induced apoptosis

References

• Kobayashi M, Suhara T, Baba Y, et al. Pathological roles of iron in cardiovascular disease. Curr Drug Targets. 2018;19(9):1068–1076.
   PubMed Web of Science ®Google Scholar
• Sanchez-Hernandez CD, Torres-Alarcon LA, Gonzalez-Cortes A, et al. Ischemia/reperfusion injury: pathophysiology, current clinical management, and potential preventive approaches. Mediators Inflamm. 2020;2020:8405370.
   PubMed Web of Science ®Google Scholar
• Wang J, Toan S, Zhou H. New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis. 2020;23(3):299–314.
   PubMed Web of Science ®Google Scholar
• Wang J, Toan S, Zhou H. Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: new insights into the mechanisms and therapeutic potentials. Pharmacol Res. 2020;156:104771.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou H. Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury. Acta Pharm Sin B. 2020;10(10):1866–1879.
   PubMed Web of Science ®Google Scholar
• Zhou H, Toan S, Zhu P, et al. DNA-PKcs promotes cardiac ischemia reperfusion injury through mitigating BI-1-governed mitochondrial homeostasis. Basic Res Cardiol. 2020;115(2):11.
   PubMed Web of Science ®Google Scholar
• Zhu H, Toan S, Mui D, et al. Mitochondrial quality surveillance as a therapeutic target in myocardial infarction. Acta Physiol (Oxf). 2021;231(3):e13590.
   PubMed Web of Science ®Google Scholar
• Ying L, Benjanuwattra J, Chattipakorn SC, et al. The role of RIPK3-regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia-reperfusion injury. Acta Physiol (Oxf). 2021;231(2):e13541.
   PubMed Web of Science ®Google Scholar
• Feng K, Ge Y, Chen Z, et al. Curcumin inhibits the PERK-eIF2alpha-CHOP pathway through promoting SIRT1 expression in oxidative stress-induced rat chondrocytes and ameliorates osteoarthritis progression in a rat model. Oxid Med Cell Longev. 2019;2019:8574386.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen A, Liang Q, et al. Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway. Aging Cell. 2021;20(6):e13377.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Lee E, You YH, et al. Role of sirtuin-1 (SIRT1) in hypoxic injury in pancreatic beta-cells. J Drug Target. 2021;29(1):88–98.
   PubMed Web of Science ®Google Scholar
• Bruder-Nascimento T, Callera GE, Montezano AC, et al. Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress. Life Sci. 2019;221:29–34.
   PubMed Web of Science ®Google Scholar
• Tremoulet AH, Jain S, Jone PN, et al. Phase I/IIa trial of atorvastatin in patients with acute kawasaki disease with coronary artery aneurysm. J Pediatr. 2019;215:107–117 e12.
   PubMed Web of Science ®Google Scholar
• Wang TF, Waller AP, Lin E, et al. A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism. Blood Coagul Fibrinolysis. 2021;32(1):16–22.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wei C, Liu J, et al. Atorvastatin protects against postoperative neurocognitive disorder via a peroxisome proliferator-activated receptor-gamma signaling pathway in mice. J Int Med Res. 2020;48(5):300060520924251.
   PubMed Web of Science ®Google Scholar
• Chu T, Huang M, Zhao Z, et al. Atorvastatin reduces accumulation of vascular smooth muscle cells to inhibit intimal hyperplasia via p38 MAPK pathway inhibition in a rat model of vein graft. Arq Bras Cardiol. 2020;115(4):630–636.
   PubMed Web of Science ®Google Scholar
• Biselli-Chicote PM, Lotierzo AT, Biselli JM, et al. Atorvastatin increases oxidative stress and inhibits cell migration of oral squamous cell carcinoma in vitro. Oral Oncol. 2019;90:109–114.
   PubMed Web of Science ®Google Scholar
• Mancini G, Martins WC, de Oliveira J, et al. Atorvastatin improves mitochondrial function and prevents oxidative stress in hippocampus following amyloid-beta1-40 intracerebroventricular administration in mice. Mol Neurobiol. 2020;57(10):4187–4201.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang C, Yan T, et al. Atorvastatin ameliorates early brain injury after subarachnoid hemorrhage via inhibition of pyroptosis and neuroinflammation. J Cell Physiol. 2021;236(10):6920–6931.
   PubMed Web of Science ®Google Scholar
• Peng S, Xu LW, Che XY, et al. Atorvastatin inhibits inflammatory response, attenuates lipid deposition, and improves the stability of vulnerable atherosclerotic plaques by modulating autophagy. Front Pharmacol. 2018;9:438.
   PubMed Web of Science ®Google Scholar
• Mounier NM, Wahdan SA, Gad AM, et al. Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(7):1537–1551.
   PubMed Web of Science ®Google Scholar
• Wu H, Tang Q, Yang J, et al. Atorvastatin ameliorates myocardial ischemia/reperfusion injury through attenuation of endoplasmic reticulum stress-induced apoptosis. Int J Clin Exp Med. 2014;7(12):4915–4923.
   PubMed Web of Science ®Google Scholar
• Rashidian A, Muhammadnejad A, Dehpour AR, et al. Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway. Inflammopharmacology. 2016;24(2–3):109–118.
   PubMed Web of Science ®Google Scholar
• Yu L, Li Q, Yu B, et al. Berberine attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation response: role of silent information regulator 1. Oxid Med Cell Longev. 2016;2016:1689602.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhai M, Li B, et al. Honokiol ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by reducing oxidative stress and apoptosis through activating the SIRT1-Nrf2 signaling pathway. Oxid Med Cell Longev. 2018;2018:3159801.
   PubMed Web of Science ®Google Scholar
• Xu S, He L, Ding K, et al. Tanshinone IIA ameliorates Streptozotocin-Induced diabetic nephropathy, partly by attenuating PERK Pathway-Induced fibrosis. Drug Des Devel Ther. 2020;14:5773–5782.
   PubMed Web of Science ®Google Scholar
• Li YP, Wang SL, Liu B, et al. Sulforaphane prevents rat cardiomyocytes from hypoxia/reoxygenation injury in vitro via activating SIRT1 and subsequently inhibiting ER stress. Acta Pharmacol Sin. 2016;37(3):344–353.
   PubMed Web of Science ®Google Scholar
• Jia W, Bai T, Zeng J, et al. Combined administration of metformin and atorvastatin attenuates diabetic cardiomyopathy by inhibiting inflammation, apoptosis, and oxidative stress in type 2 diabetic mice. Front Cell Dev Biol. 2021;9:634900.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao Q, Li X, et al. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway. Mol Cell Biochem. 2021;476(7):2803–2812.
   PubMed Web of Science ®Google Scholar
• Cao L, Chen Y, Zhang Z, et al. Endoplasmic reticulum Stress-Induced NLRP1 inflammasome activation contributes to myocardial ischemia/reperfusion injury. Shock. 2019;51(4):511–518.
   PubMed Web of Science ®Google Scholar
• Han Y, Sun W, Ren D, et al. SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion. Redox Biol. 2020;34:101538.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang P, Liu X, et al. Exogenous NAD(+) supplementation protects H9c2 cardiac myoblasts against hypoxia/reoxygenation injury via Sirt1-p53 pathway. Fundam Clin Pharmacol. 2014;28(2):180–189.
   PubMed Web of Science ®Google Scholar
• Zhang XB, Cheng HJ, Yuan YT, et al. Atorvastatin attenuates intermittent hypoxia-induced myocardial oxidative stress in a mouse obstructive sleep apnea model. Aging. 2021;13(14):18870–18878.
   PubMedGoogle Scholar
• Ren J, Liu W, Li GC, et al. Atorvastatin attenuates myocardial hypertrophy induced by chronic intermittent hypoxia in vitro partly through miR-31/PKCepsilon pathway. Curr Med Sci. 2018;38(3):405–412.
   PubMed Web of Science ®Google Scholar
• Liu P, Li J, Liu M, et al. Hesperetin modulates the Sirt1/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis. Biomed Pharmacother. 2021;139:111552.
   PubMed Web of Science ®Google Scholar
• Packer M. Differential pathophysiological mechanisms in heart failure with a reduced or preserved ejection fraction in diabetes. JACC Heart Fail. 2021;9(8):535–549.
   PubMed Web of Science ®Google Scholar
• Han D, Li X, Li S, et al. Reduced silent information regulator 1 signaling exacerbates sepsis-induced myocardial injury and mitigates the protective effect of a liver X receptor agonist. Free Radic Biol Med. 2017;113:291–303.
   PubMed Web of Science ®Google Scholar
• Wang ZK, Chen RR, Li JH, et al. Puerarin protects against myocardial ischemia/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: the role of the SIRT1/NF-kappaB pathway. Int Immunopharmacol. 2020;89(Pt B):107086.
   PubMedGoogle Scholar
• Qin Z, Gao L, Lin G, et al. The nuclear receptor co-repressor 1 is a novel cardioprotective factor against acute myocardial ischemia-reperfusion injury. J Mol Cell Cardiol. 2022;166:50–62.
   PubMed Web of Science ®Google Scholar
• Samidurai A, Ockaili R, Cain C, et al. Preclinical model of type 1 diabetes and myocardial ischemia/reperfusion injury in conscious rabbits-demonstration of cardioprotection with rapamycin. STAR Protoc. 2021;2(3):100772.
   PubMedGoogle Scholar
• Schena GJ, Murray EK, Hildebrand AN, et al. Cortical bone stem cell-derived exosomes’ therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling. Am J Physiol Heart Circ Physiol. 2021;321(6):H1014–H1029.
   PubMed Web of Science ®Google Scholar
• Toldo S, Mauro AG, Cutter Z, et al. Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2018;315(6):H1553–H1568.
   PubMed Web of Science ®Google Scholar
• Ge X, Meng Q, Wei L, et al. Myocardial ischemia-reperfusion induced cardiac extracellular vesicles harbour proinflammatory features and aggravate heart injury. J Extracell Vesicles. 2021;10(4):e12072.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang X, Zhu F, et al. A-kinase anchoring protein 5 anchors protein kinase a to mediate PLN/SERCA to reduce cardiomyocyte apoptosis induced by hypoxia and reoxygenation. Biochem Cell Biol. 2022;100(2):162–170.
   PubMedGoogle Scholar
• Zhao W, Wu Y, Ye F, et al. Tetrandrine ameliorates myocardial ischemia reperfusion injury through miR-202-5p/TRPV2. Biomed Res Int. 2021;2021:8870674.
   PubMed Web of Science ®Google Scholar
• Di Conza G, Ho PC. ER stress responses: an emerging modulator for innate immunity. Cells. 2020;9(3):695.
   PubMed Web of Science ®Google Scholar
• Fang SJ, Li PY, Wang CM, et al. Inhibition of endoplasmic reticulum stress by neuregulin-1 protects against myocardial ischemia/reperfusion injury. Peptides. 2017;88:196–207.
   PubMed Web of Science ®Google Scholar
• Li YZ, Wu H, Liu D, et al. cFLIPL alleviates myocardial Ischemia-Reperfusion injury by inhibiting endoplasmic reticulum stress. Cardiovasc Drugs Ther. 2021.
   Web of Science ®Google Scholar
• Wang XB, Huang XM, Ochs T, et al. Effect of sulfur dioxide preconditioning on rat myocardial ischemia/reperfusion injury by inducing endoplasmic reticulum stress. Basic Res Cardiol. 2011;106(5):865–878.
   PubMed Web of Science ®Google Scholar
• Wang J, Lu L, Chen S, et al. PERK overexpression-mediated Nrf2/HO-1 pathway alleviates hypoxia/reoxygenation-induced injury in neonatal murine cardiomyocytes via improving endoplasmic reticulum stress. Biomed Res Int. 2020;2020:6458060.
   PubMed Web of Science ®Google Scholar